(Q40457824)

20 September 2017

CYP450, COX-2 and Obesity Related Renal Damage. (English)

1 reference

20 September 2017

John D Imig

1

1 reference

20 September 2017

Xueying Zhao

series ordinal

2

1 reference

20 September 2017

Aparajita Dey

series ordinal

3

1 reference

20 September 2017

Marsha Shaw

series ordinal

4

1 reference

20 September 2017

1 January 2005

1 reference

Toxicology Mechanisms and Methods

20 September 2017

1 reference

20 September 2017

15

1 reference

20 September 2017

2

1 reference

20 September 2017

125-136

1 reference

Cardiac function and metabolism in Type 2 diabetic mice after treatment with BM 17.0744, a novel PPAR-alpha activator

20 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Overview: obesity: what does it have to do with kidney disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Obesity-initiated metabolic syndrome and the kidney: a recipe for chronic kidney disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Rosiglitazone reduces urinary albumin excretion in type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Induction of cytochrome P450III and P450IV family proteins in streptozotocin-induced diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Gut hormone PYY(3-36) physiologically inhibits food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Peroxisome Proliferator-Activated Receptor γ Agonist Provides Superior Renal Protection versus Angiotensin-Converting Enzyme Inhibition in a Rat Model of Type 2 Diabetes with Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Cyclooxygenase-2 inhibitor blocks expression of mediators of renal injury in a model of diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Glomerular hypertrophy is associated with hyperinsulinemia and precedes overt diabetes in aging rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Obesity and hypertension: two epidemics or one?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Rofecoxib decreases renal injury in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Altered kidney CYP2C and cyclooxygenase-2 levels are associated with obesity-related albuminuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Peripheral signals in the control of satiety and hunger

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Ten-year incidence of elevated blood pressure and its predictors: the CARDIA study. Coronary Artery Risk Development in (Young) Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

The relationship between hyperinsulinemia, hypertension and progressive renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Altered expression of hepatic CYP2E1 and CYP4A in obese, diabetic ob/ob mice, and fa/fa Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

The sympathetic system and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

PPARs and the complex journey to obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Cyclooxygenase-2 (COX-2) inhibition limits abnormal COX-2 expression and progressive injury in the remnant kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

The metabolic effects of tumor necrosis factor and other cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Peroxisome proliferator-activated receptor-gamma activity is associated with renal microvasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

The metabolic syndrome: peroxisome proliferator-activated receptor gamma and its therapeutic modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

The kidney, hypertension, and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Is obesity a major cause of chronic kidney disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Peroxisome proliferator-activated receptor delta activation promotes cell survival following hypertonic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Tumor necrosis factor alpha inhibits signaling from the insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Peroxisome proliferator-activated receptor gamma: implications for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Body weight, weight change, and risk for hypertension in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Epoxygenase metabolites. Epithelial and vascular actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Peroxisome proliferator-activated receptor (PPAR)-alpha activation prevents diabetes in OLETF rats: comparison with PPAR-gamma activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Insulin requirement for contraction of cultured rat glomerular mesangial cells in response to angiotensin II: possible role for insulin in modulating glomerular hemodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

The Zucker fatty rat as a genetic model of obesity and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

20-HETE and circulating insulin in essential hypertension with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Minireview: Adiposity, Inflammation, and Atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Glomerulosclerosis and tubulointerstitial fibrosis are attenuated with 17beta-estradiol in the aging Dahl salt sensitive rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Cellular warriors at the battle of the bulge

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Weight gain-induced blood pressure elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Troglitazone halts diabetic glomerulosclerosis by blockade of mesangial expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Promoter (4G/5G) plasminogen activator inhibitor-1 genotype in Pima Indians: relationship to plasminogen activator inhibitor-1 levels and features of the insulin resistance syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

The reno-protective role of AT(1)-receptor blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Epidemiologic trends in overweight and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Effects of weight reduction on arterial pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

P-450 metabolites of arachidonic acid in the control of cardiovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Troglitazone lowers blood pressure and enhances insulin sensitivity in Watanabe heritable hyperlipidemic rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

The metabolic syndrome as a risk factor for chronic kidney disease: more than a fat chance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Cellular mechanisms of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Diabetes, hypertension, and cardiovascular disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Blood pressure and hormone changes associated with weight reduction in the obese

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Hyperphagia as a mediator of renal disease initiation in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Protein kinase C signals thromboxane induced increases in fibronectin synthesis and TGF-beta bioactivity in mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Inhibition of COX-2 prevents hypertension and proteinuria associated with a decrease of 8-iso-PGF2alpha formation in L-NAME-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

A role for glucagon-like peptide-1 in the central regulation of feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Plasma angiotensinogen concentrations in obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Association of angiotensin converting enzyme and plasminogen activator inhibitor-1 promoter gene polymorphisms with features of the insulin resistance syndrome in patients with premature coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Downregulation of renal CYP-derived eicosanoid synthesis in rats with diet-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Positional cloning of the mouse obese gene and its human homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Kidney CYP450 enzymes: biological actions beyond drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15376520590918856

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

21 January 2018

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.1038/47254

10.1080/15376520590918856

15 July 2023

Identifiers

DOI

1 reference

20 September 2017

1 reference